Approximately 20% of children with chronic kidney disease carry a genetic mutation1. Following advances in sequencing technologies, genomic testing is increasingly being offered and accessed in renal clinics across Australia. The introduction of this service signals a series of challenges for health care professionals as well as the patients and families. Yet, there is a lack of literature exploring the impact of genomic testing in the renal clinic. The aim of this study was to use qualitative analysis to understand the psychosocial impact of genomic testing on individual patients and their families and in addition to better understand their information/service needs during the process. We recruited i) primary carers of children who have undergone genomic testing for a suspected genetic kidney disease within the last 4 years; ii) adolescents who have a proven genetic kidney disease, from The Sydney Children’s Hospital Network. Semi-structured interviews were used to investigate individual experiences of testing (including pre and post-test experiences), perceived benefits/challenges associated with genomic testing, and participant information and support needs. Interviews were transcribed, de-identified, coded and analysed for salient themes. Content and iterative thematic analysis was conducted to explain experiences. Thirteen participants (20% male, mean age = 35years) agreed to participate in a semi-structured interview. Key themes emerged; participants discussed the utility of current genomic testing, their genomic information and support needs, and concern for their child’s future. Communicated benefits of testing included the provision of an explanation for symptoms and a clarification of cause for disease, access to medications, empowerment associated with being informed and family planning provisions. Hope for future research including entry into clinical trials, and the development of targeted treatments was reported by the majority of participants. Challenges associated with genomic testing included difficulty comprehending genomic information during consultations, trouble explaining diagnosis to friends and family and dissatisfaction with length of time taken to receive test results. The need for genomic information to be simplified, specific and understandable was emphasised across all interviews. Families also expressed a desire for the provision of supplementary written and visual information and support resources to complement the information received during consultations. Participants identified the importance of developing rapport with healthcare providers, having a support network when undergoing testing and the need to provide assistance to navigate the health system. The study is ongoing but preliminary findings indicate that parents and families are likely to benefit from condition specific information resources and genetic counselling services beyond the renal clinic in order to optimise psycho-social adjustment during and after receiving genomic testing for kidney disease.